Regulation of Mesenchymal Stem Cell Secretome for Treatment of Microglia Damage in Traumatic Brain Injury
间充质干细胞分泌组的调节治疗创伤性脑损伤中的小胶质细胞损伤
基本信息
- 批准号:10626686
- 负责人:
- 金额:$ 53.9万
- 依托单位:
- 依托单位国家:美国
- 项目类别:
- 财政年份:2022
- 资助国家:美国
- 起止时间:2022-08-03 至 2024-07-31
- 项目状态:已结题
- 来源:
- 关键词:AddressAdipose tissueAgonistAlzheimer&aposs DiseaseAnti-Inflammatory AgentsAttentionAttenuatedBiologicalBiological Response Modifier TherapyBlindnessBrainCD44 geneCause of DeathCell TherapyChemistryClinicalCognitiveCommunicable DiseasesDataDiseaseDisease associated microgliaDoseEconomic BurdenEnvironmentEventGenerationsGenetic TranscriptionGoalsHealth SciencesHematologyHistologicImpaired cognitionInflammationInjuryKnowledgeLabelLaboratoriesLipopolysaccharidesMediatingMediator of activation proteinMesenchymalMesenchymal Stem CellsMessenger RNAMethodsMicrogliaModelingMolecularMolecular AnalysisMusNerve DegenerationNervous System TraumaNeurodegenerative DisordersOrganPathologyPhagocytosisPharmacologyPhenotypePre-Clinical ModelPrevalenceProcessProteinsPublic HealthPublishingRegulationResearchRetinaRoleRouteSafetySerumSignal PathwaySignal TransductionStromal CellsTBI treatmentTSG-6 proteinTYROBP geneTennesseeTestingTherapeuticTherapeutic EffectTissuesToxic effectTraumatic Brain InjuryUniversitiesVisionVisualVisual impairmentWorld Health Organizationcognitive functioncontrolled cortical impactdisabilityengineered exosomesexosomeexperiencefunctional outcomesgenetic approachimprovedimproved functioningin vivoindividualized medicineinhibitorinnovationknock-downneurovascularoverexpressionpreservationpublic health relevancereceptorregenerativeregenerative therapyresponsestemstem cell biologystem cell therapystem cells
项目摘要
ABSTRACT
The World Health Organization predicts that traumatic brain injury (TBI) will surpass many diseases, including
infectious diseases, as a significant cause of death and disabilities, including significant cognitive dysfunction
and visual impairment. Mesenchymal stem/stromal cell (MSC) therapies have gained considerable attention as
a strategy for protecting against neurodegenerative diseases. However, a poor understanding of the
mechanisms of therapeutic action has hampered their regulatory approval for clinical use. We have pioneered
the therapeutic application of adipose MSC-derived concentrated conditioned media (ASC-CCM), a "secretome"
containing soluble proteins and exosomes, for neurovascular pathologies across a range of preclinical models.
Guided by promising in vivo efficacy data and identification of TNF-Stimulated Gene-6 protein (TSG-6) as an
exosome-cargo protein that suppresses microglial activation, we now propose studies to determine if non-
invasive delivery of ASC-CCM protects against TBI-induced damage. We will test the central hypothesis that
TSG-6 enriched ASC-CCM ameliorates the generation of TBI-induced disease-associated microglia (DAM),
thereby modulating phagocytosis and inflammation to restore the microglial homeostatic state to protect visual
and cognitive function. In Aim 1, using a validated controlled cortical impact model of TBI (CCI-TBI) with and
without intranasal ASC-CCM treatment, we will a) establish the DAM phenotypic correlates of TBI-induced loss
of cognitive and visual functions and b) establish the efficacy of ASC-CCM treatment in TBI. In Aim 2, using
microglia in culture, we will determine if activation of the DAM signature through TYROBP-APOE4-axis signaling
leads to phagocytosis and inflammation and determine how exosomal TSG-6 modulates TYROBP-APOE4-
mediated DAM activation. In Aim 3, we will investigate the hypothesis that exosomes carrying TSG-6 protein are
sufficient to modulate the activation of DAM signature and thus impart the therapeutic benefit in TBI. We will
also study the distribution of exosomes in the tissues and study potential safety and toxicity. The proposed
research is significant and innovative because our expected results would provide the rationale for developing
mechanistically defined regenerative therapies tailored to modulating microglial phenotypes and signaling
pathways involved in neurodegeneration. The PI's laboratories have been engaged for nearly a decade in
developing regenerative and pharmacological therapies for neurotrauma and are well suited to conduct studies
proposed in this application. Our environment at the University of Tennessee Health Science Center and Diadem
Biotherapeutics, Inc makes us uniquely qualified to pursue this objective, given the extensive collective
experience in molecular and stem cell biology, exosome engineering, proinflammatory signaling networks, and
neurotrauma models.
摘要
世界卫生组织预测,创伤性脑损伤(TBI)将超过许多疾病,包括
传染病是死亡和残疾的重要原因,包括严重的认知功能障碍
和视力障碍。间充质干细胞/基质细胞(MSC)疗法已经获得相当大的关注,
一种预防神经退行性疾病的策略。然而,对
治疗作用机制阻碍了它们的临床应用的监管批准。我们开创
脂肪MSC衍生的浓缩条件培养基(ASC-CCM)的治疗应用,
包含可溶性蛋白质和外来体,用于一系列临床前模型中的神经血管病理学。
在有希望的体内疗效数据和TNF刺激的基因-6蛋白(TSG-6)作为肿瘤抑制剂的鉴定的指导下,
外泌体货物蛋白抑制小胶质细胞激活,我们现在提出的研究,以确定是否非-
ASC-CCM的侵入性递送保护免受TBI诱导的损伤。我们将检验中心假设,
富含TSG-6的ASC-CCM改善TBI诱导的疾病相关小胶质细胞(DAM)的产生,
从而调节吞噬作用和炎症,以恢复小胶质细胞的稳态,
和认知功能。在目标1中,使用经验证的TBI控制皮质撞击模型(CCI-TBI),
在没有鼻内ASC-CCM治疗的情况下,我们将a)建立TBI诱导的损失的DAM表型相关性,
和B)确立ASC-CCM治疗TBI的功效。在目标2中,使用
在培养的小胶质细胞中,我们将确定是否通过TYROBP-APOE 4轴信号转导激活DAM信号
导致吞噬作用和炎症,并确定外泌体TSG-6如何调节TYROBP-APOE 4-
介导的DAM激活。在目的3中,我们将研究携带TSG-6蛋白的外泌体是
足以调节DAM信号的激活,从而赋予TBI的治疗益处。我们将
还研究外泌体在组织中的分布,并研究潜在的安全性和毒性。拟议
研究是重要的和创新的,因为我们的预期结果将为开发
调节小胶质细胞表型和信号传导的机制定义的再生疗法
参与神经退化的途径。PI的实验室已经从事了近十年,
开发神经创伤的再生和药理学疗法,非常适合进行研究
本申请中提出的。我们在田纳西大学健康科学中心和Diadem的环境
Biotherapeutics,Inc使我们唯一有资格追求这一目标,鉴于广泛的集体
在分子和干细胞生物学,外泌体工程,促炎信号网络,
神经创伤模型
项目成果
期刊论文数量(0)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)
数据更新时间:{{ journalArticles.updateTime }}
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
数据更新时间:{{ journalArticles.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ monograph.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ sciAawards.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ conferencePapers.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ patent.updateTime }}
Rajashekhar Gangaraju其他文献
Rajashekhar Gangaraju的其他文献
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
{{ truncateString('Rajashekhar Gangaraju', 18)}}的其他基金
Vascular and Neuronal Repair with Adipose Stromal cells in Retinopathy
脂肪基质细胞在视网膜病变中修复血管和神经元
- 批准号:
8503030 - 财政年份:2013
- 资助金额:
$ 53.9万 - 项目类别:
Vascular and Neuronal Repair with Adipose Stromal cells in Retinopathy
脂肪基质细胞在视网膜病变中修复血管和神经元
- 批准号:
8623134 - 财政年份:2013
- 资助金额:
$ 53.9万 - 项目类别:
相似海外基金
Deciphering the role of adipose tissue in common metabolic disease via adipose tissue proteomics
通过脂肪组织蛋白质组学解读脂肪组织在常见代谢疾病中的作用
- 批准号:
MR/Y013891/1 - 财政年份:2024
- 资助金额:
$ 53.9万 - 项目类别:
Research Grant
ESTABLISHING THE ROLE OF ADIPOSE TISSUE INFLAMMATION IN THE REGULATION OF MUSCLE MASS IN OLDER PEOPLE
确定脂肪组织炎症在老年人肌肉质量调节中的作用
- 批准号:
BB/Y006542/1 - 财政年份:2024
- 资助金额:
$ 53.9万 - 项目类别:
Research Grant
Canadian Alliance of Healthy Hearts and Minds: Dissecting the Pathways Linking Ectopic Adipose Tissue to Cognitive Dysfunction
加拿大健康心灵联盟:剖析异位脂肪组织与认知功能障碍之间的联系途径
- 批准号:
479570 - 财政年份:2023
- 资助金额:
$ 53.9万 - 项目类别:
Operating Grants
Determinants of Longitudinal Progression of Adipose Tissue Inflammation in Individuals at High-Risk for Type 2 Diabetes: Novel Insights from Metabolomic Profiling
2 型糖尿病高危个体脂肪组织炎症纵向进展的决定因素:代谢组学分析的新见解
- 批准号:
488898 - 财政年份:2023
- 资助金额:
$ 53.9万 - 项目类别:
Operating Grants
Activation of human brown adipose tissue using food ingredients that enhance the bioavailability of nitric oxide
使用增强一氧化氮生物利用度的食品成分激活人体棕色脂肪组织
- 批准号:
23H03323 - 财政年份:2023
- 资助金额:
$ 53.9万 - 项目类别:
Grant-in-Aid for Scientific Research (B)
Development of new lung regeneration therapies by elucidating the lung regeneration mechanism of adipose tissue-derived stem cells
通过阐明脂肪组织干细胞的肺再生机制开发新的肺再生疗法
- 批准号:
23K08293 - 财政年份:2023
- 资助金额:
$ 53.9万 - 项目类别:
Grant-in-Aid for Scientific Research (C)
A study on the role of brown adipose tissue in the development and maintenance of skeletal muscles
棕色脂肪组织在骨骼肌发育和维持中作用的研究
- 批准号:
23K19922 - 财政年份:2023
- 资助金额:
$ 53.9万 - 项目类别:
Grant-in-Aid for Research Activity Start-up
Adipose Tissue T Cell Polarization and Metabolic Health in Persons Living with HIV
HIV 感染者的脂肪组织 T 细胞极化和代谢健康
- 批准号:
10619176 - 财政年份:2023
- 资助金额:
$ 53.9万 - 项目类别:
Estrogen Signaling in the Ventromedial Hypothalamus Modulates Adipose Tissue Metabolic Adaptation
下丘脑腹内侧区的雌激素信号调节脂肪组织代谢适应
- 批准号:
10604611 - 财政年份:2023
- 资助金额:
$ 53.9万 - 项目类别:
Obesity and Childhood Asthma: The Role of Adipose Tissue
肥胖和儿童哮喘:脂肪组织的作用
- 批准号:
10813753 - 财政年份:2023
- 资助金额:
$ 53.9万 - 项目类别: